Baxter International Inc (BAX)
35.25
+0.08
(+0.23%)
USD |
NYSE |
May 17, 16:00
35.25
0.00 (0.00%)
After-Hours: 20:00
Baxter International SG&A Expense (Quarterly): 995.00M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 995.00M |
December 31, 2023 | 935.00M |
September 30, 2023 | 1.002B |
June 30, 2023 | 964.00M |
March 31, 2023 | 914.00M |
December 31, 2022 | 875.00M |
September 30, 2022 | 941.00M |
June 30, 2022 | 970.00M |
March 31, 2022 | 1.052B |
December 31, 2021 | 860.00M |
September 30, 2021 | 684.00M |
June 30, 2021 | 678.00M |
March 31, 2021 | 627.00M |
December 31, 2020 | 696.00M |
September 30, 2020 | 601.00M |
June 30, 2020 | 589.00M |
March 31, 2020 | 628.00M |
December 31, 2019 | 1.421B |
September 30, 2019 | 627.00M |
June 30, 2019 | 641.00M |
March 31, 2019 | 601.00M |
December 31, 2018 | 628.00M |
September 30, 2018 | 684.00M |
June 30, 2018 | 681.00M |
March 31, 2018 | 610.00M |
Date | Value |
---|---|
December 31, 2017 | 730.00M |
September 30, 2017 | 688.00M |
June 30, 2017 | 630.00M |
March 31, 2017 | 564.00M |
December 31, 2016 | 670.00M |
September 30, 2016 | 726.00M |
June 30, 2016 | 709.00M |
March 31, 2016 | 641.00M |
December 31, 2015 | 733.00M |
September 30, 2015 | 794.00M |
June 30, 2015 | 783.00M |
March 31, 2015 | 784.00M |
December 31, 2014 | 860.00M |
September 30, 2014 | 827.00M |
June 30, 2014 | 988.00M |
March 31, 2014 | 910.00M |
December 31, 2013 | 496.00M |
September 30, 2013 | 975.00M |
June 30, 2013 | 838.00M |
March 31, 2013 | 795.00M |
December 31, 2012 | 999.00M |
September 30, 2012 | 743.00M |
June 30, 2012 | 789.00M |
March 31, 2012 | 752.00M |
December 31, 2011 | 886.00M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
589.00M
Minimum
Jun 2020
1.421B
Maximum
Dec 2019
835.00M
Average
867.50M
Median
SG&A Expense (Quarterly) Benchmarks
LeMaitre Vascular Inc | 20.70M |
Outset Medical Inc | 32.49M |
Becton Dickinson & Co | 1.193B |
Boston Scientific Corp | 1.364B |
ResMed Inc | 229.92M |